Navigation Links
Infection Control Association honors study on CA-MRSA
Date:5/19/2014

LOS ANGELES (May 13, 2014) Loren Miller, MD, a Los Angeles Biomedical Research Institute (LA BioMed) lead researcher, is the senior author of a published study that will receive the Association for Professionals in Infection Control and Epidemiology (APIC) Award for Publication Excellence at its annual conference in Anaheim on June 7.

With more than 15,000 members, APIC is the leading professional association seeking to create a safer world through the prevention of infection. Each year, the organization honors the authors who have published an article in the American Journal of Infection Control, which was widely read and cited during the previous year and has the potential to make an important impact on the practice of infection prevention and control.

The study the organization is honoring on June 7 measured the transmission and survival of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), which are bacteria that are resistant to many antibiotics and can cause serious skin infections.

"Congratulations to Dr. Miller and his colleagues for this recognition of their important research on one of the nation's leading health threats, CA-MRSA," said David I. Meyer, PhD, LA BioMed president and CEO. "Dr. Miller's important research is representative of the cutting-edge work underway at LA BioMed in the field of infectious diseases and antibiotic resistance. Through the research of Dr. Miller and his colleagues, we are seeking new paths for combating antibiotic resistance and improving healthcare practices to avoid the spread of MRSA and other bacteria."

In the study APIC honored, researchers applied the most common strain of CA-MRSA, USA300, to nine commonly touched items, including razor blades, children's building blocks, towels, vinyl and bars of soap. The bacteria survived and could be transmitted to the skin from each of these surfaces except for the soap. Over time, the transmissibility of CA-MRSA decreased more rapidly from porous objects, such as the towels, than from nonporous objects, such as the vinyl. The transmissibility from nonporous objects remained even after two months, suggesting these surfaces are important in the transmission of these virulent bacteria.

The researchers compared these findings with a similar test using three health-care associated strains of MRSA and found the CA-MRSA strain was transmissible for longer periods of time.

In addition to his work at LA BioMed, Dr. Miller serves as the Director of the Infection Prevention and Control Program at Harbor-UCLA Medical Center. He serves as a faculty member in the Division of Adult Infectious Diseases at Harbor-UCLA and as a Professor of Medicine at the David Geffen School of Medicine at UCLA.

Dr. Miller's primary research interests include clinical outcomes, epidemiology and molecular epidemiology of CA-MRSA infections and skin infections. He has been an investigator and principal investigator on many National Institutes of Health, Centers for Disease Control and Prevention and Agency for Healthcare Research & Quality grants related to treatment and prevention of MRSA and CA-MRSA. Dr. Miller is an author on more than 80 peer-reviewed manuscripts and book chapters.


'/>"/>

Contact: Laura Mecoy
Lmecoy@labiomed.org
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Related medicine news :

1. TB lung infection causes changes in the diversity of gut bacteria in mice
2. Expert guidance strengthens strategies to prevent most common and costly infection
3. Drug pair cuts childrens urinary infections up to 80 percent
4. Medication does not lower risk of fungal infection, death among ELBW infants
5. How bacteria exploit proteins to trigger potentially lethal infections
6. Georgia State researcher gets $2.83 million grant to develop drugs for RSV infection
7. Use of frozen material for fecal transplant successfully treats C. difficile infection
8. Pilot study suggests ways to widen access to fecal transplants for C. diff infections
9. McCullers reviews influenza, bacterial superinfections in Nature Reviews Microbiology
10. More research called for into HIV and schistosomiasis coinfection in African children
11. Rapid, broad countermeasures sought against mystery infections
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Infection Control Association honors study on CA-MRSA
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology: